ACTRN12609001035213Terminated未知
In women with asymptomatic ovarian cancer and rising cancer antigen 125 (CA-125) levels, does the use of a Decision Aid increase satisfaction and reduce difficulties with decision-making when compared to a general information booklet? A randomised controlled trial.
Centre for Medical Psychology and Evidence-based Decision-making0 sites178 target enrollmentStarted: December 4, 2009Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Terminated
- Sponsor
- Enrollment
- 178
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Educational / counselling / training
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- o limit to o limit (—)
- Sex
- Female
Inclusion Criteria
- •Women with a diagnosis of epithelial ovarian cancer, who have undergone tumour debulking / cyto-reductive surgery, have completed first-line chemotherapy, and are currently asymptomatic during follow-up with rising CA-125 levels.
Exclusion Criteria
- •Women who do not understand sufficient English to read the booklet and complete the questionnaires, have a concurrent psychiatric disorder or are cognitively impaired are not eligible for the study.
Investigators
Similar Trials
Completed
Phase 3
Phase III Randomized Trial of Maintenance Pegylated Liposomal Doxorubicin (PLD)/ Carboplatin versus without in Patients with Advanced Ovarian CancerAdvanced ovarian cancerCancer - Ovarian and primary peritonealACTRN12607000329460Chang Gung Memorial Hospital122
Completed
Not Applicable
Targeted screening for ovarian cancer in women over 50 years of age with vague presenting symptomsOvarian cancerMalignant neoplasm of ovaryCancerISRCTN04011070Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Not yet recruiting
Unknown
To find out how the latest drugs will Help Breast and Ovarian Cancer Patients in Eastern India with Gene Problems.CTRI/2023/11/059748INSTITUTE OF MEDICAL SCIENCES AND SUM HOSPITA
Completed
Not Applicable
Early detection of ovarian cancer and response prediction: TEP and ctDNA study.ovarian tumorNL-OMON50170Catharina-ziekenhuis200
Completed
Not Applicable
Sentinel node in ovarian cancermalignancy of the ovary10038594ovarian cancerNL-OMON37538Medisch Universitair Ziekenhuis Maastricht28